Why is Godavari Drugs falling/rising?

As of 18-Aug, Godavari Drugs Ltd's stock price is currently at 85.85, reflecting an increase of 0.85 or 1.0%. Today's price summary indicates that the stock has outperformed its sector by 0.77% and has experienced a trend reversal, gaining after two consecutive days of decline. However, the stock's performance over the past week shows a decrease of 0.64%, and it has underperformed the benchmark Sensex over the past month and year-to-date, with returns of -1.94% and -21.49%, respectively. The stock is trading at a discount compared to its peers, but it has faced significant challenges, including a 41.2% decline in profits over the past year and negative results for the last three consecutive quarters.
Broader market context reveals that while the Sensex has shown a positive return of 0.83% over the past week, Godavari Drugs has struggled with a long-term performance that includes a -15.00% return over the last year and underperformance against the BSE500 in various time frames. The company's weak long-term fundamentals, characterized by a high Debt to EBITDA ratio and declining operating profits, further contribute to investor concerns. Despite a recent uptick in price, the overall sentiment remains cautious due to the company's declining financial health and falling investor participation.